Köpenysejtes limfóma: vizsgálatok itt: Dél-Korea
6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Where
- Daejeon, Seoul
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06084936 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Where
- GangnamGu, SeochoGu, Seogu, Seoul, SongpaGu, Yeongdeungpo-gu
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06742996 · EU 2024-515593-27-00 - 1/2. fázisTaking peopleA Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Where
- Busan, Seoul
- Életkor
- 18 év and over
- People
- 408 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06564038 · EU 2024-515034-33-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- GangnamGu, SeochoGu, SeodaemunGu, Seogu, Seoul, SongpaGu
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 2. fázisTaking peopleA Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma
- Where
- Seoul
- Életkor
- 60 év and over
- People
- 90
- Run by
- Kim, Seok Jin
See details and how to joinNCT05245656